Ex vivo autolymphocyte therapy: Added Canadian sites to an on-going U.S. Phase III trial

Cellcor Inc. (CLTX), Newton, Mass. Product: Ex vivo autolymphocyte therapy to activate patients' killer and helper T cells before infusion Indication: Metastatic kidney cancer Status: Added Canadian s...